Inbrain Neuroelectronics closes €14.3 million round

Inbrain Neuroelectronics, spun-off from the Catalan Institute of Nanoscience and Nanotechnology (ICN2) and Icrea (and associated with the Graphene Flagship) , recently announced closing a $16.85 million (€14.3 million) round led by Asabys and Alta. The company has also received financial backing from Cdti and two international investors.

Inbrain Neuroelectronics closes €14.3 million round image

NBRAIN Neuroelectronics was established in 2019 with the mission of developing brain-implants based on graphene technology for applications in patients with epilepsy, Parkinson’s, and other neuronal diseases. These smart devices, built around an innovative graphene electrode, will decode with high certainty neural signals from the brain and produce a therapeutic response adapted to the clinical condition of the specific patient.

Read More | Graphene-Info
Medicine, Graphene Flagship, Graphene investing and financials